Paraneoplastic cerebellar degeneration: II. cerebellar degeneration, cancer, and the lambert–eaton myasthenic syndrome

Neurology

Volumn 42, Issue 10, 1992, Pages 1944-1950

  Clouston, P D ^a   Saper, C B ^b   Arbizu, T ^c   Johnston, I ^d   Lang, B ^d   Newsom Davis, J ^d   Posner, Jerome B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CS “Principes de España” ^*  (Spain)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; CANCER DIAGNOSIS; CEREBELLUM DEGENERATION; CEREBROSPINAL FLUID ANALYSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PURKINJE CELL;

AGED; AUTOANTIBODIES; CEREBELLAR DISEASES; FEMALE; HUMAN; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MIDDLE AGE; NEOPLASMS; NEURONS; PARANEOPLASTIC SYNDROMES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026801046     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.42.10.1944     Document Type: Article

References (33)

1. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988;24:559-567.
2. Hammack JE, Kimmel DW, O’Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 1990;65:1423-1431.
3. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neu- ronopathy: a clinical study of 71 patients. Medicine 1992;71:59-72.
4. Apderson NE, Budde-Steffen C, Wiley RG, et al. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurology 1988;38;1018- 1026.
5. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin’s disease. Neurology 1992;42:1938-1943.
6. Scher E, Gotti C, Canal N, et al. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 1989;2:640-643.
7. Leys K, Lang B, Johnston I, Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol 1991;29:307-314.
8. Lambert EH, Rooke ED. Myasthenic state and lung cancer. In: Brain R, Norris FH. The remote effects of cancer on the nervous system. New York, NY: Grune and Stratton, 1970:67-79.
9. Steffanson K, Marton LS, Dieperink ME. Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science 1985;228:1117-1119.
10. Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in diseases of the motor unit. JAMA 1957;163:1117-1124.
11. Rooke ED, Eaton LM, Lambert EH, Hodgeson CH. Myasthenia and malignant intrathoracic tumor. Med Clin North Am 1960;44:977-988.
12. O’Neill JH, Murray NMF, Newsom-Davis J. The Lambert- Eaton myasthenic syndrome: a review of 50 cases. Brain 1988;111:577-596.
13. Fukuhara N, Masarahu T, Gutmann L, Chou S. Eaton- Lambert syndrome: ultrastructural study of the motor end- plates. Arch Neurol 1972;27:67-78.
14. Satoyoshi E, Kowa H, Fukunaga N. Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchogenic carcinoma: a case report. Neurology 1973;23:764-768.
15. Blank NK, Rieder MJ. Myasthenic syndrome and subacute cerebellar degeneration. Lancet 1974;1:1003-1004.
16. Takahashi K, Takao T, Nakamura H, Fukuda M. Autopsy of lung cancer associated with Eaton-Lambert syndrome and subacute cerebellar degeneration—with special reference to the effect of streptomycin!. RinshoShinkeigaku 1975;15:415-422.
17. Zweifel T, Albert JW. Multiple neurologic paraneoplastic syndromes: report of a case. Arch Neurol 1980;37:315-316.
18. Greenberg HS. Paraneoplastic cerebellar degeneration: a clinical and CT study. J Neurooncol 1984;2:377-382.
19. Okita N, Ohara Y, Kobayashi K. (A case of lung cancer associated with subacute cerebellar degeneration and Eaton- Lambert syndrome). Igaku-no-Ayumi 1981;118:156-166.
20. Tsukamoto T, Yamamoto H, Iwasaki Y, et al. Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration. Arch Neurol 1989;46:1225-1229.
21. Ishida T, Kinoshita M, Ebe H, Minegishi A, Nonaka H. (Case of Eaton-Lambert syndrome and subacute cerebellar degeneration: prolonged observation before the onset of lung cancer). Rinsho Shinkeigaku 1983;23:963-969.
22. Konig F, Rohrmoser B. Myasthenes syndrom Lambert- Eaton, subakute corticale cerebellare degeneration und sensomotorische polyneuropathie bei kleinzelliegem bronchialcarcinom. (Eaton-Lambert syndrome, subacute cerebellar degeneration and peripheral sensorimotor neuropathy with small-cell bronchogenic carcinoma). Nervenarzt 1984;55:436-440.
23. Kurahashi K, Abe Y, Kurihara A, Takebe K, Matsunaga M. (Plasma cascade filtration therapy in a case of subacute cerebellar degeneration associated with Eaton-Lambert type of neuromuscular block). Rinsho Shinkeigaku 1986;26:137- 142.
24. Tanaka K, Tanaka M, Miyatake T, Yamamoto A, Kurahashi K, Matsunaga M. Antibodies to brain proteins in a patient with subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome. Tohoku J Exp Med 1987;153:161-167.
25. Kobayashi H, Matsuoka R, Kitamura S, Watanabe K, Kiro S. Bronchogenic carcinoma with subacute cerebellar degeneration and Eaton-Lambert syndrome: an autopsy case. Jpn J Med 1988;27:203-206.
26. Blumenfeld AM, Recht LD, Chad DA, DeGirolami U, Griffin T, Jaeckle KA. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 1991;41:1682-1685.
27. Henson RA, Urich H. Cortical cerebellar degeneration. In: Henson RA, Urich H, eds. Cancer and the nervous system: the neurological manifestations of systemic malignant disease. 1st ed. Oxford, UK: Blackwell Scientific, 1982:346-367.
28. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985;35:538-543.
29. Dalmau J, Furneaux HM, Gralla RK, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small-cell lung cancer: a quantitative Western blot analysis. Ann Neurol 1990;27:544-552.
30. Dropcho EJ, Stanton C, Oh SJ. Neuronal antinuclear antibodies in a patient with Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Neurology 1989;39:249-251.
31. Kaptain GJ, Brashear HR, Keeney PM, Tabbara I. Antineuronal antibodies in patients with small-cell carcinoma [abstract]. Neurology 1991;41(suppl 1):239.
32. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel—conotoxin complexes from small-cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504.
33. Lang B, Vincent A, Murray NMF, Newsom-Davis J. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity. Ann Neurol 1989;5:265-271.